Detalhe da pesquisa
1.
Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14).
Blood
; 117(14): 3809-15, 2011 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-21310923
2.
NPM1 is overexpressed in hyperdiploid multiple myeloma due to a gain of chromosome 5 but is not delocalized to the cytoplasm.
Genes Chromosomes Cancer
; 49(4): 333-41, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20073075
3.
Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability.
Blood
; 111(9): 4700-5, 2008 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18305218
4.
Identification of HLA-A2 restricted T-cell epitopes within the conserved region of the immunoglobulin G heavy-chain in patients with multiple myeloma.
Eur J Haematol
; 81(1): 26-35, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18363871
5.
TACI expression is associated with a mature bone marrow plasma cell signature and C-MAF overexpression in human myeloma cell lines.
Haematologica
; 92(6): 803-11, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17550853
6.
Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma.
Exp Hematol
; 34(4): 486-96, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16569595
7.
Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells.
Oncogene
; 24(21): 3512-24, 2005 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-15735670
8.
High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by multiprobe interphase FISH.
Cancer Genet Cytogenet
; 161(2): 116-24, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16102581
9.
Ultrasensitive PCR detection of tumor cells in myeloma.
Methods Mol Biol
; 226: 185-96, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12958500
10.
Melan-A/MART1 analog peptide triggers anti-myeloma T-cells through crossreactivity with HM1.24.
J Immunother
; 32(6): 613-21, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19483648
11.
Cancer/testis genes in multiple myeloma: expression patterns and prognosis value determined by microarray analysis.
J Immunol
; 178(5): 3307-15, 2007 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17312182
12.
CD200 is a new prognostic factor in multiple myeloma.
Blood
; 108(13): 4194-7, 2006 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16946299
13.
Targeting positive regulatory domain I-binding factor 1 and X box-binding protein 1 transcription factors by multiple myeloma-reactive CTL.
J Immunol
; 175(2): 1301-9, 2005 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16002735
14.
The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature.
Blood
; 106(3): 1021-30, 2005 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15827134
15.
Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics.
Genes Chromosomes Cancer
; 44(2): 194-203, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16001433
16.
Dissociation of putative graft-versus-haematopoiesis and graft-versus-myeloma effects in patients with rapidly progressive multiple myeloma.
Br J Haematol
; 123(4): 646-53, 2003 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-14616968
17.
Post-transplantation tumour load in bone marrow, as assessed by quantitative ASO-PCR, is a prognostic parameter in multiple myeloma.
Br J Haematol
; 126(5): 665-74, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15327517